TSE:141A stock news
This page provides real-time market news, earnings updates, and company announcements related to TRIAL Holdings.Inc. (TSE:141A).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-26 15:38 JST
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-25 13:03:48
Obagi Medical and It's a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ
Finviz2026-02-25 13:30:09
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago
Finviz2026-02-25 13:34:26
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago
Finviz2026-02-25 13:34:26
PolyPid Announces Participation in Upcoming Investor Conferences
Finviz2026-02-25 13:39:26
Longeveron Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
Finviz2026-02-25 16:09:44
Eli Lilly (LLY) Releases Positive Results From Phase 3 VIVID-2 Open-Label Extension Study
Finviz2026-02-25 16:13:23
BEAM Reports Smaller-Than-Anticipated Q4 Loss, Year-Over-Year Revenue Growth
101 finance2026-02-25 17:10:18
Salesforce’s Earnings Are the Software Market’s AI Moment of Truth
101 finance2026-02-25 17:54:48
TMDX Shares Climb After Q4 Earnings and Revenue Surpass Expectations
101 finance2026-02-25 17:57:51
Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment
Finviz2026-02-25 18:24:03
Delta's AI Pricing Experiment: A Small-Scale Trial, Not a Significant Controversy
101 finance2026-02-25 19:27:41
BVF's $52M Investment in Disc Medicine: Interpreting the Discrepancy in Expectations Following the FDA CRL
101 finance2026-02-25 21:01:01
Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-25 21:03:43
PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance
Finviz2026-02-25 21:06:49
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-25 21:09:44
Larimar Secures $75M: Evaluating Financial Structure and Risk Premium Prior to a Major Catalyst
101 finance2026-02-25 21:21:50
Johnson & Johnson's 0.45% Mysterious Slide Without Clear Catalyst Despite 54th-Ranked $1.87B Volume
101 finance2026-02-25 22:33:36
BMY Falls 0.49% with 122nd Trading Volume Rank as FDA Acceptance and Earnings Miss Drive Mixed Investor Sentiment
101 finance2026-02-25 23:03:50
Medtronic's Slight 0.10% Decline Conceals 173rd-Highest $660M Trading Volume Amid Industry Consolidation
101 finance2026-02-25 23:16:05
Regeneron Gains 1.57% as FDA Decision Nears, Trading Volume Ranks 207th
101 finance2026-02-25 23:24:45
eBay Shares Edge Up as Company Resolves Decade-Long Harassment Case, Ranking 226th in Trading Volume
101 finance2026-02-25 23:30:45
RBC Capital Sees Merck (MRK) Returning to Growth Sooner Than Market Expects
Finviz2026-02-26 02:51:37
Tesla Rival Xpeng Expands Robotics Bet With Guangzhou Factory For Optimus Challenger IRON
Finviz2026-02-26 04:42:11
PolyPid Announces Participation in Upcoming Investor Conferences
Finviz2026-02-25 13:39:26
Longeveron Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
Finviz2026-02-25 16:09:44
Eli Lilly (LLY) Releases Positive Results From Phase 3 VIVID-2 Open-Label Extension Study
Finviz2026-02-25 16:13:23
BEAM Reports Smaller-Than-Anticipated Q4 Loss, Year-Over-Year Revenue Growth
101 finance2026-02-25 17:10:18
Salesforce’s Earnings Are the Software Market’s AI Moment of Truth
101 finance2026-02-25 17:54:48
TMDX Shares Climb After Q4 Earnings and Revenue Surpass Expectations
101 finance2026-02-25 17:57:51
Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment
Finviz2026-02-25 18:24:03
Delta's AI Pricing Experiment: A Small-Scale Trial, Not a Significant Controversy
101 finance2026-02-25 19:27:41
BVF's $52M Investment in Disc Medicine: Interpreting the Discrepancy in Expectations Following the FDA CRL
101 finance2026-02-25 21:01:01
Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-25 21:03:43
PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance
Finviz2026-02-25 21:06:49
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-25 21:09:44
Larimar Secures $75M: Evaluating Financial Structure and Risk Premium Prior to a Major Catalyst
101 finance2026-02-25 21:21:50
Johnson & Johnson's 0.45% Mysterious Slide Without Clear Catalyst Despite 54th-Ranked $1.87B Volume
101 finance2026-02-25 22:33:36
BMY Falls 0.49% with 122nd Trading Volume Rank as FDA Acceptance and Earnings Miss Drive Mixed Investor Sentiment
101 finance2026-02-25 23:03:50
Medtronic's Slight 0.10% Decline Conceals 173rd-Highest $660M Trading Volume Amid Industry Consolidation
101 finance2026-02-25 23:16:05
Regeneron Gains 1.57% as FDA Decision Nears, Trading Volume Ranks 207th
101 finance2026-02-25 23:24:45
eBay Shares Edge Up as Company Resolves Decade-Long Harassment Case, Ranking 226th in Trading Volume
101 finance2026-02-25 23:30:45
RBC Capital Sees Merck (MRK) Returning to Growth Sooner Than Market Expects
Finviz2026-02-26 02:51:37
Tesla Rival Xpeng Expands Robotics Bet With Guangzhou Factory For Optimus Challenger IRON
Finviz2026-02-26 04:42:11
TSE:141A stock price change
On the last trading day, TSE:141A stock closed at 3890.00 JPY, with a price change of 21.94% for the day.
Trade stock perpsTSE:141A stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more